[In vitro activity of ertapenem against strains isolated from diabetic foot infections.] - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Médecine et Maladies Infectieuses Année : 2008

[In vitro activity of ertapenem against strains isolated from diabetic foot infections.]

Résumé

OBJECTIVE: The authors had for aim to evaluate the in vitro activity of ertapenem against bacterial strains isolated from diabetic foot infections (DFI). METHODOLOGY: All diabetic patients hospitalized for a first episode of DFI (stages 2 to 4, according to the International Working Group of Diabetic Foot Classification) were selected in the N?s University hospital between January 2005 to December 2005. MICs were determined using both E-test((R)) strips and dilution methods on bacterial strains isolated from foot samples. RESULTS: Two hundred and fifty-two bacteria (154 Gram-positive cocci including 94 Staphylococcus aureus, 80 Gram-negative bacilli with 56 Enterobacteriaceae, and 18 anaerobes) were studied. Ertapenem was active against all Streptococcus spp., Enterobacteriaceae, anaerobes, and also against 89.8% of methicillin-susceptible S. aureus isolates. However, this antibiotic was active only against 31.5% of Staphylococcus epidermidis, 21.8% of Enterococcus faecalis, and 15.8% of Pseudomonas aeruginosa. CONCLUSION: Our results indicate that ertapenem may be a useful agent to treat patients suffering from DFI after bacterial identification.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-00258593 , version 1 (22-02-2008)

Identifiants

Citer

Albert Sotto, Xavier Lemaire, Nathalie Jourdan, Nicole Bouziges, Jean-Louis Richard, et al.. [In vitro activity of ertapenem against strains isolated from diabetic foot infections.]. Médecine et Maladies Infectieuses, 2008, epub ahead of print. ⟨10.1016/j.medmal.2007.11.018⟩. ⟨inserm-00258593⟩
29 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More